Works matching DE "TREATMENT of chronic myeloid leukemia"

Results: 752

Nilotinib Meets Primary Endpoint in Pivotal Trial Against Imatinib as First-Line Treatment in Chronic Myeloid Leukemia Patients.

Published in:: Oncology (08909091), 2009, v. 23, n. 12, p. 1104
Publication type:: Article

Chronic Phase Chronic Myeloid Leukemia: More Drugs, More Lives Saved, New Challenges.

Published in:

2007

By:

Tefferi, Ayalew;
Litzow, Mark

Publication type:

Editorial

The Unfolding Story of Imatinib Mesylate for Chronic Myeloid Leukemia.

Published in:

2007

By:

Goldman, John M.

Publication type:

Editorial

Optimal First-Line Treatment of Chronic Myeloid Leukemia: How to Use Imatinib and What Role for Newer Drugs?

Published in:

Oncology (08909091), 2007, v. 21, n. 6, p. 653

By:

Jabbour, Elias;
Cortes, Jorge;
Kantarjian, Hagop

Publication type:

Article

New Options to Treat Chronic Myeloid Leukemia, Overcome Imatinib Resistance.

Published in:: Oncology (08909091), 2007, v. 21, n. 1, p. 110
Publication type:: Article

Imatinib Sets New Treatment Standard in Patients With Chronic Myeloid Leukemia.

Published in:: Oncology (08909091), 2006, v. 20, n. 8, p. 935
Publication type:: Article

Long-term treatment effects in chronic myeloid leukemia.

Published in:

Journal of Mathematical Biology, 2017, v. 75, n. 3, p. 733, doi. 10.1007/s00285-017-1098-5

By:

Besse, Apollos;
Lepoutre, Thomas;
Bernard, Samuel

Publication type:

Article

CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 4, p. 383, doi. 10.1007/s00228-009-0772-y

By:

Gréen, Henrik;
Skoglund, Karin;
Rommel, Franz;
Mirghani, Rajaa;
Lotfi, Kourosh

Publication type:

Article

Drug monitoring of imatinib levels in patients undergoing therapy for chronic myeloid leukaemia: comparing plasma levels of responders and non-responders.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 6, p. 545, doi. 10.1007/s00228-009-0621-z

By:

Singh, N.;
Kumar, L.;
Meena, R.;
Velpandian, T.

Publication type:

Article

Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data.

Published in:

Bioinformatics, 2012, v. 28, n. 6, p. 823, doi. 10.1093/bioinformatics/bts059

By:

Yeung, K. Y.;
Gooley, T. A.;
Zhang, A.;
Raftery, A. E.;
Radich, J. P.;
Oehler, V. G.

Publication type:

Article

Analysis of the pharmacoeconomic effectiveness of the tyrosine kinase inhibitors therapy in patients with chronic myeloid leukemia in a Single Hematology Center in Plovdiv, Bulgaria.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e126016

By:

Goranova-Marinova, Veselina;
Grekova-Kafalova, Daniela;
Andreevska, Kalina;
Georgieva, Vania;
Gvozdeva, Yana;
Kassarova, Margarita;
Grudeva-Popova, Zhanet;
Gavazova, Evelina;
Petkova, Valentina

Publication type:

Article

Nilotinib Interferes with the Signalling Pathways Implicated in Acetaminophen Hepatotoxicity.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2014, v. 114, n. 3, p. 263, doi. 10.1111/bcpt.12144

By:

Shaker, Mohamed E.

Publication type:

Article

L-Amino Acid Oxidase Isolated from Bothrops pirajai Induces Apoptosis in BCR- ABL-Positive Cells and Potentiates Imatinib Mesylate Effect.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 2, p. 103, doi. 10.1111/bcpt.12073

By:

Burin, Sandra M.;
Ayres, Lorena R.;
Neves, Renata P.;
Ambrósio, Luciana;
Morais, Fabiana R.;
Dias‐Baruffi, Marcelo;
Sampaio, Suely V.;
Pereira‐Crott, Luciana S.;
Castro, Fabíola A.

Publication type:

Article

Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6777, doi. 10.3892/ol.2018.8112

By:

Martínez-Castillo, Macario;
Villegas-Sepúlveda, Nicolas;
Meraz-Rios, Marco A.;
Hernández-Zavala, Araceli;
Berumen, Jaime;
Coleman, Mathew A.;
Orozco, Lorena;
Cordova, Emilio J.

Publication type:

Article

Suv4-20h1 promotes G1 to S phase transition by downregulating p21WAF1/CIP1 expression in chronic myeloid leukemia K562 cells.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6123, doi. 10.3892/ol.2018.8092

By:

Wu, Yupeng;
Wang, Yadong;
Liu, Ming;
Nie, Min;
Wang, Ying;
Deng, Yexuan;
Yao, Bing;
Gui, Tao;
Li, Xinyu;
Ma, Lingling;
Guo, Chan;
Ma, Chi;
Ju, Junyi;
Zhao, Quan

Publication type:

Article

Long‑lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Published in:

Oncology Letters, 2018, v. 15, n. 3, p. 2935, doi. 10.3892/ol.2017.7720

By:

Jo, Tatsuro;
Noguchi, Kazuhiro;
Hayashi, Shizuka;
Irie, Sadaharu;
Hayase, Risa;
Shioya, Haruna;
Kaneko, Youhei;
Horio, KENsuke;
Taguchi, Jun

Publication type:

Article

Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia.

Published in:

Oncology Letters, 2018, v. 15, n. 2, p. 2419, doi. 10.3892/ol.2017.7606

By:

Koçkan, Betül;
Toptaş, Tayfur;
Atagündüz, Işik;
Tuğlular, Ayşe Tülin;
Özer, Ayşe;
Akkiprik, Mustafa

Publication type:

Article

Therapeutic immune monitoring of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.

Published in:

Oncology Letters, 2017, v. 14, n. 2, p. 1363, doi. 10.3892/ol.2017.6294

By:

ZIYUAN LU;
NA XU;
XUAN ZHOU;
GUANLUN GAO;
LIN LI;
JIXIAN HUANG;
YULING LI;
QISI LU;
BOLIN HE;
CHENGYUN PAN;
XIAOLI LIU

Publication type:

Article

Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.

Published in:

2017

By:

YUKIKO KOMENO;
NAOYUKI UCHIDA;
YUMIKO SATOH;
HIDEKI URYU;
YUKO IWATA;
AKIKO MASUDA;
KUNIKO IIHARA;
YUTAKA YATOMI;
SHUICHI TANIGUCHI;
TOMIKO RYU

Publication type:

Case Study

Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.

Published in:

Oncology Letters, 2016, v. 11, n. 3, p. 2290, doi. 10.3892/ol.2016.4165

By:

YALÇINTEPE, LEMAN;
HALIS, EMRE;
ULKU, SIBEL

Publication type:

Article

Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases.

Published in:

2016

By:

HUIFANG JIANG;
ZHONGLIN WU;
LI REN;
DIEHONG TAO;
HONGYAN TONG

Publication type:

Case Study

Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report.

Published in:

Oncology Letters, 2015, v. 9, n. 4, p. 1957, doi. 10.3892/ol.2015.2928

By:

SHIUE-WEI LAI;
TZU-CHUAN HUANG;
JIA-HONG CHEN;
YI-YING WU;
PING-YING CHANG

Publication type:

Article

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase.

Published in:

Oncology Letters, 2014, v. 7, n. 3, p. 791, doi. 10.3892/ol.2014.1780

By:

FANKAI MENG;
WEN ZENG;
LIFANG HUANG;
SHUANG QIN;
NINGNING MIAO;
HANYING SUN;
CHUNRUI LI

Publication type:

Article

Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia.

Published in:

Molecular & Clinical Oncology, 2016, v. 4, n. 1, p. 89, doi. 10.3892/mco.2015.653

By:

YUTAKA TSUTSUMI;
SHINICHI ITO;
HIROYUKI OHIGASHI;
SOUICHI SHIRATORI;
TAKANORI TESHIMA

Publication type:

Article

Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.

Published in:

Frontiers in Psychology, 2019, p. N.PAG, doi. 10.3389/fpsyg.2019.00329

By:

Borghi, Lidia;
Galimberti, Sara;
Baratè, Claudia;
Bonifacio, Massimiliano;
Capochiani, Enrico;
Cuneo, Antonio;
Falzetti, Franca;
Iurlo, Alessandra;
Lunghi, Francesca;
Minotto, Claudia;
Orlandi, Ester Maria;
Rege-Cambrin, Giovanna;
Sica, Simona;
Supekar, Sharon;
Haenig, Jens;
Vegni, Elena

Publication type:

Article

Gastrointestinal stromal tumors: past, present, and future.

Published in:

Journal of Gastroenterology, 2008, v. 43, n. 7, p. 499, doi. 10.1007/s00535-008-2200-y

By:

Kitamura, Yukihiko

Publication type:

Article

Treatments for chronic myeloid leukemia: a qualitative systematic review.

Published in:

Journal of Blood Medicine, 2012, v. 3, p. 51, doi. 10.2147/JBM.S33380

By:

Ferdinand, Roxanne;
Mitchell, Stephen A.;
Batson, Sarah;
Tumur, Indra

Publication type:

Article

Ponatinib given for advanced leukemia relapse after allo-SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 599, doi. 10.1038/bmt.2014.301

By:

Hirschbuehl, K;
Rank, A;
Pfeiffer, T;
Slawik, H R;
Schlimok, G;
Kolb, H J;
Schmid, Ch

Publication type:

Article

An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 11, p. 1352, doi. 10.1038/bmt.2014.176

By:

Adekola, K;
Popat, U;
Ciurea, S O

Publication type:

Article

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 6, p. 837, doi. 10.1038/bmt.2012.234

By:

Basak, G W;
de Wreede, L C;
van Biezen, A;
Wiktor-Jedrzejczak, W;
Halaburda, K;
Schmid, C;
Schaap, N;
Dazzi, F;
von dem Borne, P A;
Petersen, E;
Beelen, D;
Abayomi, A;
Volin, L;
Buzyn, A;
Gurman, G;
Bunjes, D;
Guglielmi, C;
Olavarria, E;
de Witte, T

Publication type:

Article

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 810, doi. 10.1038/bmt.2011.194

By:

Khoury, H J;
Kukreja, M;
Goldman, J M;
Wang, T;
Halter, J;
Arora, M;
Gupta, V;
Rizzieri, D A;
George, B;
Keating, A;
Gale, R P;
Marks, D I;
McCarthy, P L;
Woolfrey, A;
Szer, J;
Giralt, S A;
Maziarz, R T;
Cortes, J;
Horowitz, M M;
Lee, S J

Publication type:

Article

Allo-SCT in a rare t(8;21) evolution of CML.

Published in:

2010

By:

Hsiao, H. H.;
Tsai, H. J.;
Liu, Y. C.;
Lee, C. P.;
Lin, S. F.

Publication type:

Letter

Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2008, v. 42, p. S40, doi. 10.1038/bmt.2008.282

By:

Suttorp, M.

Publication type:

Article

Allogeneic stem cell transplantation for chronic myeloid leukemia–status in 2007.

Published in:

Bone Marrow Transplantation, 2008, v. 42, p. S11, doi. 10.1038/bmt.2008.105

By:

Goldman, J. M.

Publication type:

Article

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach.

Published in:

2020

By:

Ector, Geneviève ICG;
Westerweel, Peter E;
Hermens, Rosella PMG;
Braspenning, Karin AE;
Heeren, Barend CM;
Vinck, Oscar MF;
Jong, Jan JM de;
Janssen, Jeroen JWM;
Blijlevens, Nicole MA;
de Jong, Jan Jm

Publication type:

journal article

Radotinib-induced lentiginosis: a report of an adverse cutaneous reaction associated with a tyrosine kinase inhibitor.

Published in:

Clinical & Experimental Dermatology, 2016, v. 41, n. 2, p. 162, doi. 10.1111/ced.12706

By:

Won, K. H.;
Jo, S. Y.;
Lee, Y. J.;
Chang, S. E.

Publication type:

Article

Multiple squamous cell carcinomas following introduction of nilotinib.

Published in:

Clinical & Experimental Dermatology, 2014, v. 39, n. 7, p. 791, doi. 10.1111/ced.12388

By:

Peters, P.;
Rabbolini, D.;
Sinnya, S.;
Khosrotehrani, K.;
Wagner, G.

Publication type:

Article

Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph+ Acute Lymphoblastic Leukaemia.

Published in:

Drugs, 2017, v. 77, n. 1, p. 85, doi. 10.1007/s40265-016-0677-x

By:

Keating, Gillian

Publication type:

Article

Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor.

Published in:

Annals of Gastroenterology, 2016, v. 29, n. 4, p. 551, doi. 10.20524/aog.2016.0053

By:

Saif, Muhammad Wasif;
Smith, Melissa Hennessey;
Maloney, Antonia;
Diasio, Robert B.

Publication type:

Article

Chronic Myeloid Leukemia (CML) in Children: Classical and Newer Therapeutic Approaches.

Published in:

Pediatric Hematology & Oncology, 2012, v. 29, n. 5, p. 389, doi. 10.3109/08880018.2012.691946

By:

Ampatzidou, Maria;
Papadhimitriou, Stefanos I.;
Goussetis, Evgenios;
Panagiotou, John P.;
Papadakis, Vassilios;
Polychronopoulou, Sophia

Publication type:

Article

Pattern of Pediatric Chronic Myeloid Leukemia in Sudan and Hematological Response to Imatinib.

Published in:

Pediatric Hematology & Oncology, 2011, v. 28, n. 2, p. 100, doi. 10.3109/08880018.2010.512949

By:

Alkhatib, Mohammed Awad

Publication type:

Article

The combination therapy of imatinib and dasatinib achieves long-term molecular response in two imatinib-resistant and dasatinibintolerant patients with advanced chronic myeloid leukemia.

Published in:

Journal of Biomedical Research, 2016, v. 30, n. 6, p. 525, doi. 10.7555/JBR.30.20130172

By:

Yu Zhu;
Liangqin Pan;
Ming Hong;
Weixing Liu;
Chun Qiao;
Jianyong Li;
Sixuan Qian

Publication type:

Article

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 4937, doi. 10.2147/OTT.S102504

By:

Pinilla-Ibarz, Javier;
Sweet, Kendra L.;
Corrales-Yepez, Gabriela M.;
Komrokji, Rami S.

Publication type:

Article

Bilateral Proliferative Retinopathy as the Initial Presentation of Chronic Myeloid Leukemia.

Published in:

2013

By:

Macedo, Mafalda S. F.;
Figueiredo, Ana R. M.;
Ferreira, Natália N.;
Barbosa, Irene M. A.;
Furtado, Maria João F. B. S.;
Correia, Nuno F. C. B. A.;
Gomes, Miguel P.;
Lume, Miguel R. B.;
Menéres, Maria João S.;
Santos, Marinho M. N.;
Meireles, M. Angelina C. S.

Publication type:

Case Study

THERAPEUTIC SUCCESS IN CHRONIC MYELOID LEUKAEMIA-ACCELERATED PHASE AT ONSET.

Published in:

Therapeutics, Pharmacology & Clinical Toxicology, 2014, v. 18, n. 2, p. 83

By:

Oana, Patrinoiu;
Daniela, Georgescu

Publication type:

Article

Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia.

Published in:

BMC Medical Genomics, 2016, v. 9, p. 51, doi. 10.1186/s12920-016-0194-5

By:

Kihoon Cha;
Yi Li;
Gwan-Su Yi

Publication type:

Article

Development of dental awareness concerning oral health behavior among students of selected universities in Krakow.

Published in:

2018

By:

LOSTER, Zofia;
GUT, Aleksander;
ZAWADA, Magdalena;
SZCZEKLIK, Katarzyna;
JAKUBIK, Anna;
PYTKO-POLOŃCZYK, Jolanta

Publication type:

Letter to the Editor

Current and future place of ponatinib in the treatment of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia - an update.

Published in:

2018

By:

WĄCŁAW, Joanna;
SACHA, Tomasz

Publication type:

Letter to the Editor

Current and future place of ponatinib in the treatment of chronic myeloid leukemia and Ph+ acute lymphocytic leukemia.

Published in:

Review of Medicine / Przeglad Lekarski, 2018, n. 3, p. 125

By:

Wącław, Joanna;
Sacha, Tomasz

Publication type:

Article

Sticker shock.

Published in:: Nature Medicine, 2013, v. 19, n. 6, p. 653, doi. 10.1038/nm.3244
Publication type:: Article